Make An Appointment Make A Payment Event Registration
Make an appointment

Donato Ricci, M.D.

Donato Ricci, M.D.

Dr. Donato R. Ricci is originally from New York City where he attended and graduated from Hunter College. He went on to obtain his medical degree from Ross University School of Medicine in 1983. His residency was completed at Mount Sinai Hospital and VA Hospital in New York City. He served his gastroenterology fellowship at Western Pennsylvania Hospital from 1986 to 1988. He is board certified in Internal Medicine and Gastroenterology.

Office locations

Port Orange Office
Ormond Beach East Office

Practicing since

1992

Certifications

  • American Board of Internal Medicine, Board Certified, 2009
  • American Board of Gastroenterology, Board Certified, 2013

Licensure

Florida, Virginia


Communicate with your physician’s staff through My BGC Health.

Professional Clinical Positions

Professional Clinical Positions
2008 - Present Borland-Groover Clinic, P.A. Port Orange, Florida
1995 - 2008 Gastrointestinal Associates, P.A. Port Orange, Florida
1992 - 1995 Private (solo) Practice, Volusia Gastroenterology, P.A.

Administrative and Leadership Positions

Administrative and Leadership Positions
1993 - Present Physician Advisor and Reviewer Florida Medical Quality Assurance
1994 - 1996 Chairman Southeast Investigational Review Board (Review of Drug Protocols)
1995 - 1996 Chairman, Medical Care Committee Halifax Medical Center, Daytona Beach, Florida
1994 - 1995 Chief, Department of Internal Medicine Halifax Medical Center, Daytona Beach, Florida
1988 - 1995 Chief, Gastroenterology Services Florida Health Care Plan, Inc. Daytona Beach, Florida
1991 - 1994 Chairman, Infection Control Committee Halifax Medical Center, Daytona Beach, Florida

Medical Education

Medical Education
1979 - 1982 University of Noreste Tampico, Mexico
1982 - 1983 M.D., Ross University School of Medicine Dominica, West Indies

Postgraduate Education

Postgraduate Education
1986 - 1988 Gastroenterology Fellowship Program Western Pennsylvania Hospital Pittsburgh, Pennsylvania
1983 - 1986 Internal Medicine Residency Program Bronx VA Hospital and Mount Sinai Hospital New York City, New York

Undergraduate Education

Undergraduate Education
1974 - 1978 B.A., Hunter College City University of New York New York, New York

Professional Associations

  • American College of Physicians
  • American College of Gastroenterology
  • American Gastroenterological Association
  • American Society for Gastrointestinal Endoscopy
  • Volusia County Medical Society
  • Florida Medical Association
  • American Society of Internal Medicine
  • Physician Member of Crohn’s/Colitis Foundation of America
  • ASTRAZENECA - Protocol # 322-325 Erosive Esophagitis Study, Present
  • SOLVAY PHARMACEUTICALS - Protocol #S2413010 - A Double-blind, Randomized, Placebo-controlled Multicenter Study to Investigate the Long Term Safety of 2mg PRN of Cilansetronin Diarrhea-Predominant Irritable Bowel Syndrome Subjects, March 2002 - February 2003
  • TAP PHARMACEUTICALS - Protocol #M02-410 - A Study to Evaluate the Effect of Lanzoprazole 30mg QD versus Esomeprazole 40mg QD on Healing and Symptom Relief in Subjects with Erosive Esophagitis, August 2002 - Decemeber 2002
  • SHERRING-PLOUGH HEP-C STUDY - Protocol #244-11-00 - Comparison of Peg-Interferon Alpha-2b plus Ribavirin given as a fixed dose or on a weight optimized basis for treatment of chronic hepatitis-C in previously untreated adults subjects, June 2001 - December 2002
  • RELIANT PHARMACEUTICALS - Protocol #REL-AX-002 - A multicenter, double-blinded, randomized study to compare the safety and efficacy of nizatidine extended release, April 2001 - July 2001
  • MERCK & CO., INC. - Protocol #MK-0966 A multicenter, randomized, parallel group, actine and placebo - controlled double-blinded study, March 2001 - January 2002
  • RELIANT PHARMACEUTICALS - Protocol #Rel-AX-001 - A multicenter, double-blinded, randomized study to compare the safety and efficacy of nizatidine extended release, March 2001 - July 2001
  • ATRA ZENECA - Protocol #267 A comparative efficacy study of esomeprazole magnesium (40MG QD) and lansoprazole (30MG QD) in patients with erosive esophagitis, June 2000 - February 2001
  • MERCK Research - Protocol #MK-0663 No. 026-00 - Incidence of gastroesophageal ulcers in patients with rheumatoid arthritis (naproxen vs. placebo), January 2000 - December 2000
  • NOVARTIS QUINTILES - Protocol #CHFT 9190358 tegaserod vs. placebo in females with irritable bowel syndrome, January 2000 - March 2000
  • SEARLE VALDECOXIB - 047 valdecoxib vs. naproxen in patients with osteoarthritis or rheumatoid arthritis, June 1999 - December 2000
  • Diagnostic Services - Blood Draw Study Colonic Polyps vs. Cancer, May 1999 - May 2000
  • PARKE-DAVIS Pharmaceutical research protocol #1004-031-5 - A randomized double-blind placebo-and-positive-controlled, parallel-group, multicenter, dose-ranging study of darbufelone mesylate (CI-1004) in patients with osteoarthritis of the knee, March 1999 - October 1999
  • TAP Holdings, Inc. Protocol # M97-671: A Study to Evaluate the Effects of Lansoprazole 30mg QD or 15mg QD versus Placebo in Patients with Non-Ulcer Dyspepsia, February 1999 - December 1999
  • TAP Holdings, Inc. Protocol #EM-97-032: Study to Evaluate the Effect of EM574, 5mg QID, 10mg TID, 20mg BID versus Placebo in Females with Non-Erosive Gastroesophageal Reflux Disease
  • TAP Holdings, Inc. Protocol #M98-890: A Study to Evaluate the Effect of Lansoprazole 30mg QD versus Omeprazole 20mg QD on Relief of Symptoms in Patients with Erosive Reflux Esophagitis, February 1999 - March 1999
  • Glaxo Wellcome: Protocol # S3B30006 May Randomized, Double-Blind placebo controlled study of ALOSETRON (GR 68755) 1 mg b.i.d. in Female subjects with Irritable Bowel Syndrome, January 1999 - June 1999
  • ASTRA 222 - A comparative efficacy and safety study of H199/18 (40MG) and OMEPRAZOLE (20MG) in study subjects with erosive esophagitis, January 1999 - September 1999
  • Astra-Merck Erosive Esophagitis Study, September 1998 - December 1998
  • TAP Holdings Inc. Dyspepsia M97-671, August 1998 - December 1998
  • Searle SC-58635/10X-2 Comparative Incidence of UGI Ulcer: Diclofenac and Ibuprofen in OA/RA, September 1997 - December 1997
  • TAP - Effects of Lansoprazole vs. Placebo In patients with non-ulcer dyspepsia, August 1997 - December 1997
  • Parke-Davis, Protocol # CI 1004-4 Dose Range Study Efficacy of CI 1004 in patients with RA, June 1997 - December 1997
  • TAP Holdings, Inc. Protocal #M95-352: A Study to Evaluate the Effects of Lansoprazole Compared with Ranitidine on NSAID- Induced Gastric Ulcers in Patients Continuing to Take NSAIDS, January 1997 - June 1997
  • G.D. Searle - Cox 2 Study OA-N49-02-022 RA-N49-96-02-21, August 1996 - December 1996
  • Smith Kline (229) Clinical Endoscopic effects of Nabumetone and Oxaprozin In elderly patients with OA of knees/hips, July 1996 - August 1997
  • Arthrotec - Safety of Arthrotec 75 b.i.d. for OA NNA 95-02-355, April 1996 - July 1997
  • Lilly - GERD Study - E3810-A001-309, 1995 - 1996
  • Janssen Research Foundation Protocol #CIS-USA-46: Clinical Evaluation of Propulsid (cisapride) Tablets - In the Treatment of subjects with Symptoms of Chronic Gastroesophageal Reflux Disease, 1995 - 1996
  • G.D. Searle - Prevention of Gastric Ulcer associated with NSAID’s, 1992 - 1993
  • G.D. Searle - Healing of Gastric Ulcer associated with NSAID’s, 1992 - 1993
  • Glaxo Pharmaceuticals - RAN-481 Duodenal ulcer associated with NSAID’s, 1992 - 1993
  • Glaxo Pharmaceuticals - RAN-482 Duodenal ulcer associated with NSAID’s, 1992 - 1993
  • Glaxo Pharmaceuticals - RAN-483 Maintenance of healed gastric and duodenal Ulcers associated with NSAID’s, 1992 - 1993
  • Glaxo Pharmaceuticals - RAN-498 Gastric and duodenal ulcers associated with NSAID’s, 1992 - 1993
  • Smith Kline Beecham Pharmaceuticals 12 week placebo controlled, randomized multicenter, double blind study on controlled release for the treatment of erosive GERD. Protocol #92334/245, 1992 - 1993
  • G.H. Besealaar - Irritable bowel syndrome study, 1991 - 1993
  • Provocative investigation of the esophagus in evaluation of on-cardiac chest pain, 1986 - 1988